Lobaplatin inhibits prostate cancer progression in part by impairing AR and ERG signal. (12th September 2018)

Record Type:: Journal Article
Title:: Lobaplatin inhibits prostate cancer progression in part by impairing AR and ERG signal. (12th September 2018)
Main Title:: Lobaplatin inhibits prostate cancer progression in part by impairing AR and ERG signal
Authors:: Hofer, Matthias D.
Abstract:
Is Part Of:: Fundamental & clinical pharmacology. Volume 32:Number 5(2018)
Journal:: Fundamental & clinical pharmacology
Issue:: Volume 32:Number 5(2018)
Issue Display:: Volume 32, Issue 5 (2018)
Year:: 2018
Volume:: 32
Issue:: 5
Issue Sort Value:: 2018-0032-0005-0000
Page Start:: 547
Page End:: 547
Publication Date:: 2018-09-12
Subjects:: Pharmacology -- Periodicals
615.1
Journal URLs:: http://www.blackwell-synergy.com/member/institutions/issuelist.asp?journal=fcp ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1472-8206 ↗
http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1111/fcp.12410 ↗
Languages:: English
ISSNs:: 0767-3981
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 4056.033000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 7513.xml